Pine Street Capital Partners Completes Successful 2012
Pine Street Capital Partners is pleased to announce an active and successful 2012. Highlights include:
A successful exit from Double E Companies LLC, representing our seventh full realization out of nine investments in PSCP I.
Five new investments and one follow-on investment for PSCP II, with three transactions highlighted below closed in December.
• PSCP invested mezzanine debt and preferred equity to support the acquisition of Eye Health Vision Centers by current portfolio company Koch Eye Associates. Eye Health is a comprehensive vision health company in Southeastern Massachusetts. PSCP co-invested in this transaction with Candescent Partners, Eagle Private Capital, First New England Capital, Bay Capital and Plexus Capital.
• PSCP invested mezzanine debt to recapitalize Scotia Technology, a Laconia, NH based niche supplier of tube assembly components for the aircraft and aerospace industries. Scotia is majority owned by Gemini Investors.
• PSCP invested mezzanine debt and preferred equity in connection with the acquisition of Merrill Industries, a packaging company providing corrugated packaging solutions to industrial customers located primarily in Southern New England. Merrill is located in Ellington, CT. PSCP co-invested with Shoreham Capital, Prodos Capital Management and Advantage Capital Connecticut I, a fund co-managed by Advantage Capital Partners and Ironwood Capital Connecticut.
A final fundraising close for Pine Street Capital Partners II, LP and the addition of Anabelle Desangles in our Wellesley, MA office.
We are actively seeking investments which meet our criteria, and we are committed to responding quickly to opportunities in a thoughtful and transparent manner. We look forward to working with you in 2013.
About Pine Street Capital Partners
Pine Street Capital Partners (PSCP) is a multi-fund management company formed in 2004. PSCP’s latest fund, Pine Street Capital Partners II, LP, continues our strategy of investing subordinated debt and non-control equity in smaller established companies with experienced and committed management teams, providing capital for buyouts, recapitalizations, acquisitions and corporate growth. PSCP has a broad investment mandate, with a preference for niche manufacturers, business services, health care and later stage IT companies. We will invest $2-6 million per transaction either as sole investor or as part of a larger investor group.